News
- Author:
- Kari Oakes
Publish date: October 29, 2019
CHICAGO – Physicians can shape the outcome of a trend that’s about to explode.
News
- Author:
- Kari Oakes
Publish date: October 26, 2019
Many patients didn’t recall ever receiving instruction about when to drive again.
Video
- Author:
- Kari Oakes
Publish date: October 26, 2019
PARIS – The balance is shifting because cardiovascular deaths are way down in high-resource nations.
News
- Author:
- Kari Oakes
Publish date: October 15, 2019
PARIS – The pragmatic study’s neutral results can inform care of most acute heart failure patients.
News
- Author:
- Kari Oakes
Publish date: October 15, 2019
Sexual harassment, hurtful sex-based comments, gender-based barriers to career advancement – and salary – top the list.
News
- Author:
- Kari Oakes
Publish date: October 15, 2019
Putting a name to persistent and insidious gender bias helps address the problem, say female physicians.
News
- Author:
- Kari Oakes
Publish date: October 15, 2019
STOCKHOLM – Oligoclonal band status is helpful for diagnosis, but cannot predict who will go on to develop clinically definite MS.
News
- Author:
- Kari Oakes
Publish date: October 9, 2019
STOCKHOLM – Patients with MS saw the best results with the most intensive memory strategies.
News
- Author:
- Kari Oakes
Publish date: October 8, 2019
STOCKHOLM – Ten-year data strengthen neurofilament light’s potential prognostic role.
News
- Author:
- Kari Oakes
Publish date: October 3, 2019
STOCKHOLM – The first-ever head-to-head trial compared the two drugs in highly relapsing neuromyelitis optica spectrum disorder.
News
- Author:
- Kari Oakes
Publish date: September 23, 2019
NEW YORK – A gentle hand and good patient education are keys to oral mucosal techniques.
News
- Author:
- Kari Oakes
Publish date: September 17, 2019
PARIS – Though dosing questions remain, the Japanese AFIRE study affirms current U.S. and European practice.
News
- Author:
- Kari Oakes
Publish date: September 17, 2019
STOCKHOLM – Younger patients had a significantly higher risk of recurrence when stopping disease modifying therapy.
News
- Author:
- Kari Oakes
Publish date: September 15, 2019
STOCKHOLM – Attacks were significantly reduced and a marker for tissue damage dropped, but IgG levels will likely have to be tracked long term.
News
- Author:
- Kari Oakes
Publish date: September 13, 2019
STOCKHOLM – Though skipping contrast missed a small number of lesions, most patients would still have been classified and treated correctly.
